AR and myocardial ischemia: Ultimately, the review also offers a detailed inspection of a selection of widely investigated AR targeting molecules, supported by experimental and clinical outcomes, in order to endorse further a possible broadened scope for these agents (beyond traditional pharmacological use), including to serve as lead candidates in drug discovery programmes which focus on the identification of effective AR-targeted therapeutics in IHD.